Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Nov 26, 2024; 12(33): 6595-6603
Published online Nov 26, 2024. doi: 10.12998/wjcc.v12.i33.6595
Published online Nov 26, 2024. doi: 10.12998/wjcc.v12.i33.6595
Prothrombotic state and thrombotic events in COVID-19 pandemic period, including portal vein and splenic artery thromboses
Ozgur Karcioglu, Department of Emergency Medicine, University of Health Sciences, Istanbul Education and Research Hospital, Istanbul 34140, Bakırkoy, Türkiye
Canan Akman, Department of Emergency Medicine, Canakkale Onsekiz Mart University, Canakkale 17000, Çanakkale, Türkiye
Göksu Afacan Ozturk, Department of Emergency Medicine, Istanbul Aydin University, Istanbul 34295, Kucukcekmece, Istanbul, Türkiye
Co-first authors: Ozgur Karcioglu and Canan Akman.
Author contributions: Karcioglu O and Akman C contribute equally to this study as co-first authors. Karcioglu O, Akman C, and Ozturk GA designed the research study; Karcioglu O, Akman C, and Ozturk GA contributed to original draft preparation, and data curation; Karcioglu O, Akman C, and Ozturk GA analyzed the data and wrote the manuscript; all authors have read and approved the final manuscript.
Conflict-of-interest statement: Author(s) certify that there is no conflict of interest related to the manuscript. If any potential conflict-of-interest exists, author(s) certify that it is fully disclosed.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ozgur Karcioglu, MD, Academic Research, Full Professor, Senior Researcher, Department of Emergency Medicine, University of Health Sciences, Istanbul Education and Research Hospital, Fatih, Istanbul 34140, Bakırkoy, Türkiye.
Received: May 26, 2024
Revised: August 2, 2024
Accepted: August 23, 2024
Published online: November 26, 2024
Processing time: 123 Days and 11.8 Hours
Revised: August 2, 2024
Accepted: August 23, 2024
Published online: November 26, 2024
Processing time: 123 Days and 11.8 Hours
Core Tip
Core Tip: Venous thromboembolisms constitute a common complication of coronavirus disease 2019 (COVID-19) and mostly manifest as deep venous thromboses, pulmonary embolism, myocardial infarction or catheter-related thromboembolic events. On the other hand, portal vein and splenic artery thromboses are rarely encountered. Since the portal vein forms the confluence of the splenic and superior mesenteric veins, portal vein thrombosis may extend to the splenic or superior mesenteric veins. Prophylactic dose anticoagulation is associated with favorable efficacy and safety in those with COVID-19, including portal vein and splenic artery thromboses.